9 Nov 2012 17:01
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
End of Stabilisation Notice
MD Medical Group Investments plc (the "Company")
Pursuant to Article 9(3) of Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC), Deutsche Bank AG, London Branch (Contact: Paul Huysmans; Telephone: 020 7547 4836) hereby gives notice that stabilisation (within the meaning of the rules of the Financial Services Authority) was undertaken by the Stabilising Manager named below in relation to the offer of the following securities.
Issuer: | MD Medical Group Investments plc |
| |||||||||||||||||||||||||||||||
Securities: | Global Depositary Receipts |
| |||||||||||||||||||||||||||||||
Description of offer: | Initial Public Offering |
| |||||||||||||||||||||||||||||||
ISIN Code: | US55279C2008 |
| |||||||||||||||||||||||||||||||
Offer price: | USD 12.00 per Global Depositary Receipt |
| |||||||||||||||||||||||||||||||
Stabilising Manager: | Deutsche Bank AG, London Branch |
| |||||||||||||||||||||||||||||||
Stabilisation period: | From 12 October 2012 to 9 November 2012
|
| |||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of MD Medical Group Investments in any jurisdiction.
The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States or to US persons unless the securities are registered under the Securities Act, or an exemption from the registration requirements of the Securities Act is available. No public offering of the securities will be made in the United States.